subscribeSubscribe
Henlius’ Pertuzumab Biosimilar Shows Similar PK Profile to Reference Product

Henlius’ Pertuzumab Biosimilar Shows Similar PK Profile to Reference Product
Deana Ferreri CENTERFORBIOSIMILARS
02 Jul 2022
Share Share
Roche launches antibody drug for breast cancer in India

Roche launches antibody drug for breast cancer in India
ECONOMIC TIMES
13 May 2022
Share Share
Chugai gets Japanese approval for Perjeta, Herceptin in HER-2 positive CC

Chugai gets Japanese approval for Perjeta, Herceptin in HER-2 positive CC
PHARMABIZ
29 Mar 2022
Share Share
BMS` Opdivo hits more approvable goal in early NSCLC

BMS` Opdivo hits more approvable goal in early NSCLC
Aakash Babu SEEKINGALPHA
09 Nov 2021
Share Share
UK cancer centre to offer breast cancer treatment at home

UK cancer centre to offer breast cancer treatment at home
Lucy Parsons PHARMATIMES
26 Apr 2021
Share Share
Meeting highlights from the Committee for Medicinal Products for Human Use

Meeting highlights from the Committee for Medicinal Products for Human Use
EMA
13 Nov 2020
Share Share
Roche wards off Herceptin copycats with Perjeta combo product

Roche wards off Herceptin copycats with Perjeta combo product
Carly Helfand FIERCE PHARMA
01 Jul 2020
Share Share
FDA approves Roche’s Phesgo for HER2-positive breast cancer

FDA approves Roche’s Phesgo for HER2-positive breast cancer
PRESS RELEASE
30 Jun 2020
Share Share
FDA Approves Breast Cancer Treatment That Can Be Administered

FDA Approves Breast Cancer Treatment That Can Be Administered
PRNEWSWIRE
29 Jun 2020
Share Share
Seattle Genetics Announces the Approval of TUKYSA™ (tucatinib)

Seattle Genetics Announces the Approval of TUKYSA™ (tucatinib)
BUSINESSWIRE
12 May 2020
Share Share